The reason for this difference might be that there was no synthetic lethal interactions between PARP1 and BRCA1/BRCA2 in lung cancer or there might be existed other types of synthetic lethal interactions, which is supported by recent studies [22, 23]. Here, BRCA1 is linked to lung carcinoma.